Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non‐small cell lung cancer: a prospective phase II study (GASTO‐1053)
Authors
Fangjie Liu (ORCID: https://orcid.org/0000-0002-5207-5157)
Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non‐small cell lung cancer: a prospective phase II study (GASTO‐1053)
Fangjie Liu, ShiYang Zheng, Tao Zhang, Bo Qiu et al.
Citations
2 citations
Journal
Cancer Communications
Topics
Brain Metastases and Treatment
Field-Weighted Citation Impact (FWCI)
3.04
article
Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non‐small cell lung cancer: a prospective phase II study (GASTO‐1053)
Fangjie Liu, ShiYang Zheng, Tao Zhang, Bo Qiu, QiaoTing Luo, Biaoshui Liu, Hongmei Zhang, Daquan Wang, Jun Zhang, Bin Wang, Hui Liu, Rui Zhou, Hui Liu, Fang Dong, Yonggao Mou, Kangqiang Peng
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer CommunicationsVol. 45(12)
Institutions
Sun Yat-sen University (CN), Key Laboratory of Guangdong Province (CN), General Hospital of Guangzhou Military Command (CN), Gansu Provincial Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), United Imaging Healthcare (China) (CN), Sun Yat-sen University Cancer Center (CN), State Key Laboratory of Oncology in South China, Chongqing Medical University (CN), South China University of Technology (CN)